CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −422 | $564.30 | $238K | 28,254 |
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,131 | $565.44 | $1.2M | 26,123 |
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,796 | $566.39 | $1.0M | 24,327 |
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −2,785 | $568.48 | $1.6M | 21,542 |
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,304 | $568.43 | $741K | 20,238 |
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,322 | $569.56 | $753K | 18,916 |
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −40 | $570.18 | $23K | 18,876 |
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −2,500 | 0 | ||
| 2026-05-18 | EDGEMOND JAMES CFO AND TREASURER | Option exercise · Stock Option 10b5-1 | −7,500 | 80,000 | ||
| 2026-05-18 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
| 2026-05-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −133 | $563.01 | $75K | 49,880 |
| 2026-05-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −365 | $564.11 | $206K | 49,515 |
| 2026-05-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,811 | $565.34 | $1.0M | 47,704 |
| 2026-05-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,117 | $566.33 | $1.2M | 45,587 |
| 2026-05-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,280 | $567.45 | $1.3M | 43,307 |
| 2026-05-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,437 | $568.33 | $817K | 41,870 |
| 2026-05-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,077 | $569.42 | $613K | 40,793 |
| 2026-05-18 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $569.99 | $160K | 40,513 |
| 2026-05-18 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 211,910 | ||
| 2026-05-15 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $146.03 | $1.4M | 50,013 |
Page 101 of 121 · 2,404 trades